Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumanta Kumar Pal

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
CA: a Cancer Journal for Clinicians|November 3, 2025
CA turns 75: Looking at the future but never forgetting the rootsDon S Dizon, Sumanta Kumar Pal, Banu E Symington, et al.
Breast Cancer Research and Treatment|June 5, 2010
Papillary carcinoma of the breast: an overviewSumanta Kumar Pal, Sean K Lau, Laura Kruper, et al.
Palliative & Supportive Care|June 19, 2018
Biopsychosocial distress and clinical outcome in metastatic renal cell carcinomaCristiane Decat Bergerot, Karen Lynn Clark, Kimlin Tam Ashing, et al.
Frontiers in Oncology|February 7, 2019
Sources of Frustration Among Patients Diagnosed With Renal Cell CarcinomaCristiane Decat Bergerot, Dena Battle, Paulo Gustavo Bergerot, et al.
International Journal of Cancer|May 12, 2020
Physical activity and risk of bladder cancer among postmenopausal womenYueyao Li, Michael S Hendryx, Pengcheng Xun, et al.
Cancer|October 2, 2020
Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance statusCristiane Decat Bergerot, Errol J Philip, Paulo Gustavo Bergerot, et al.
Investigational New Drugs|March 28, 2021
A first-in-human phase I study of TAS0728, an oral covalent binding inhibitor of HER2, in patients with advanced solid tumors with HER2 or HER3 aberrationsSarina A Piha-Paul, Analía Azaro, Hendrik Tobias Arkenau, et al.
Journal of Geriatric Oncology|August 12, 2019
Association between chemotherapy toxicity risk scores and physical symptoms among older Brazilian adults with cancerCristiane Decat Bergerot, Marianne Razavi, Errol J Philip, et al.
Molecular Cancer Therapeutics|October 10, 2015
Clinical and Translational Assessment of VEGFR1 as a Mediator of the Premetastatic Niche in High-Risk Localized Prostate CancerSumanta Kumar Pal, Winston Vuong, Wang Zhang, et al.
Urologic Oncology|October 11, 2021
Fighting the 'tobacco epidemic' - A call to action to identify Targeted Intervention Points (TIPs) for better counseling patients with urothelial cancerGiovanni E Cacciamani, Richard S Matulewicz, Raj Kumar, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
CA: a Cancer Journal for Clinicians|November 3, 2025
CA turns 75: Looking at the future but never forgetting the rootsDon S Dizon, Sumanta Kumar Pal, Banu E Symington, et al.
Breast Cancer Research and Treatment|June 5, 2010
Papillary carcinoma of the breast: an overviewSumanta Kumar Pal, Sean K Lau, Laura Kruper, et al.
Palliative & Supportive Care|June 19, 2018
Biopsychosocial distress and clinical outcome in metastatic renal cell carcinomaCristiane Decat Bergerot, Karen Lynn Clark, Kimlin Tam Ashing, et al.
Frontiers in Oncology|February 7, 2019
Sources of Frustration Among Patients Diagnosed With Renal Cell CarcinomaCristiane Decat Bergerot, Dena Battle, Paulo Gustavo Bergerot, et al.
International Journal of Cancer|May 12, 2020
Physical activity and risk of bladder cancer among postmenopausal womenYueyao Li, Michael S Hendryx, Pengcheng Xun, et al.
Cancer|October 2, 2020
Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance statusCristiane Decat Bergerot, Errol J Philip, Paulo Gustavo Bergerot, et al.
Investigational New Drugs|March 28, 2021
A first-in-human phase I study of TAS0728, an oral covalent binding inhibitor of HER2, in patients with advanced solid tumors with HER2 or HER3 aberrationsSarina A Piha-Paul, Analía Azaro, Hendrik Tobias Arkenau, et al.
Journal of Geriatric Oncology|August 12, 2019
Association between chemotherapy toxicity risk scores and physical symptoms among older Brazilian adults with cancerCristiane Decat Bergerot, Marianne Razavi, Errol J Philip, et al.
Molecular Cancer Therapeutics|October 10, 2015
Clinical and Translational Assessment of VEGFR1 as a Mediator of the Premetastatic Niche in High-Risk Localized Prostate CancerSumanta Kumar Pal, Winston Vuong, Wang Zhang, et al.
Urologic Oncology|October 11, 2021
Fighting the 'tobacco epidemic' - A call to action to identify Targeted Intervention Points (TIPs) for better counseling patients with urothelial cancerGiovanni E Cacciamani, Richard S Matulewicz, Raj Kumar, et al.
Pageof 10